Funding for this research was provided by:
Breast Cancer Now
Text and Data Mining valid from 2019-12-31
Received: 26 July 2019
Accepted: 4 November 2019
First Online: 31 December 2019
Ethics approval and consent to participate
: Ethical approval for POETIC (Trial Number CRUK/07/015) was provided by NRES Committee London–South-East. All patients consented to molecular analysis of their samples for research purposes.
: All authors approved the final version of this manuscript.
: MD and LAM receive academic funding from Pfizer, Puma Biotechnology Inc., and AstraZeneca. MD receives honoraria from Myriad Genetics and speaker’s bureau of Roche; is a consultant and advisory board member of Radius, GTx, and Orion Pharma; and has received remuneration from the ICR rewards to Inventors Schemes. MCUC has a patent: US Patent No. 9,631,239 with royalties paid. All other authors declare that they have no competing interests.